Persons Reported to be living with HIV infection and with AIDS reported
Year Adults/Adolescents Children Under 13 Years old Total Cumulative Totals
  HIV AIDS HIV AIDS HIV AIDS Adults / Adolescents Children Under 13 Years old Total
2000 474 482 5 4 479 486 956 9 965
2001

539

518

 6 4 545 522 1,057 10 1,067
2002 591 563 7 4 598 567 1,154 11 1,165
                   

 

 

HIV Infection Cases  from areas with confidential HIV infection reporting
Year   Cumulative Totals
    Adults / Adolescents Children Under 13 Years old Total
2000 60 497 6 503
2001 90 565 8 573
2002 53 591 7 598
         

 

Adult/Adolescent HIV infection and AIDS cases reported in the United States
Year Males Females
  HIV AIDS HIV AIDS
2000 46 58 14 21
2001 68 63 20 11
         

 

New Pediatric AIDS cases reported

Year
2000 0
2001 0

 

AIDS cases and annual rates per 100,000 population by Metropolitan area reported through 2001

 

 1999

2000

2001

Cumulative Totals
City No No. No. Adults / Adolescents Children under 13 Years old Total

Omaha

 44 53 54 808 3 811

 

Cumulative AIDS Cases

Cumulative Number of AIDS Cases, Reported through 2002 1,237
Cumulative Number of Adult/Adolescent AIDS Cases, Reported through 2002 1,227
Cumulative Number of AIDS Cases in Children <13, Reported through 2002 10

Distribution of Cumulative Adult/Adolescent AIDS Cases by Gender, Reported through June 2002
  NE USA
Men 1,030 680,909
Women 159 146,298
Total 1,189 827,208

 

New AIDS Cases

New AIDS Cases, Reported through 2002 70
New Adult/Adolescent AIDS Cases, Reported in 2001 74
New AIDS Cases in Children <13, Reported through December 2001 0

Distribution of New Adult/Adolescent AIDS Cases by Gender, Reported in 2001
  NE USA
Men 63 31,901
Women 11 11,082
Total 74 42,983

 

Persons Living with AIDS

Estimated Number of Persons Living with AIDS at the End of 2002 567
Estimated Number of Adults/Adolescents Living with AIDS at the End of 2002 563
Estimated Number of Children Living with AIDS at the End of 2002 4
HIV Infection Cases Reported in 2002 53

 

Total Deaths Reported through 2000, due to AIDS = 684
HIV Reporting Requirements ?   Yes, Name Based.
 
HIV Testing Options?  Anonymous and Confidential testing
Definitions: Anonymous test: Individual does NOT use their name, and a name is not associated with test result. Anonymous tests are offered at anonymous testing centers, available in many, but not all, states.
Confidential test: Individual DOES use their name. If test is positive, individual's name will be known to their health care provider and, potentially, to other health care professionals and, in some cases, your state's Department of Health.
 
HIV Testing for Mothers and Newborns
Voluntary or Mandatory Testing?  Voluntary HIV testing; no specific law. State follows CDC guidelines; No specific law or language on testing for mothers and newborns.
Voluntary HIV Testing: All states and the District of Columbia have certified to the CDC that they have measures in place to implement the CDC's 1995 recommendations on HIV counseling and testing of pregnant women.  The CDC's 1995 recommendations state that HIV testing of pregnant women and infants should be voluntary and providers must obtain informed consent for testing as required by their state laws.  Voluntary testing is noted if the state follows the CDC guidelines but does not have specific guidelines for testing of mothers and newborns.
 
Status of State Medicaid Expansion Efforts for People with HIV
Approved 1115 Waiver, TWWIIA demonstration? NO
Definitions: 1115 Waivers: Section 1115 of the Social Security Act authorizes the executive branch of the Federal government to waive the statutory and regulatory provisions of the Medicaid program. States have used "1115 waivers" to make changes in eligibility, benefits, and other areas of their Medicaid programs. The Centers for Medicare and Medicaid Services (CMS--formerly known as the Health Care Financing Administration) and several states have been analyzing the implications of expanding Medicaid eligibility to people with HIV prior to disability through the use of Section 1115 waivers of the Social Security Act. To use 1115 waivers, states face several challenges, particularly the need to demonstrate "budget neutrality" to the Medicaid program - that the costs of an expansion over a designated period of time (usually 5 years) would not exceed the costs to Medicaid in the absence of the expansion.
Ticket to Work/Work Incentives Improvement Act of 1999: TWWIIA expanded State options under Medicaid by creating new Medicaid buy-in options for working individuals with disabilities and extended Medicare cover-age for working individuals with disabilities. The Act also authorized state demonstration programs to provide Medicaid to workers with potentially severe disabilities, including HIV/AIDS, who are not yet disabled but whose health conditions could be expected to cause disability.
Notes: Most people with HIV who qualify for Medicaid do so by meeting the program’s income and disability standards once their illness has already progressed. Many low income people with HIV may be faced with of having their eligibility postponed until they become disabled, even though there are therapies available that may prevent disability and national treatment guidelines recommend access to early treatment. 1115 Waivers and TWWIIA demonstrations are two ways in which states have sought to address this limitation.

 
Sterile Syringe Exchange Programs?  No
Notes: U.S. totals include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and independent nations in free association with the United States.
Definitions: Programs in operation: includes both state-sanctioned syringe exchange programs and non-sanctioned programs. Because their operation may not necessarily be authorized, it is difficult to account for an exact number of syringe exchange programs operation across the country; therefore, the list may not be comprehensive.
 
STD/HIV/AIDS Education Requirement?  No, If taught voluntarily, there are no state-specific content requirements.
Minors' Right to Consent to HIV/STD Services?  Yes
 

 

 
Total Ryan White Funding, FY2000   $1,782,207 FY2002  $2,429,384

 

CDC HIV Prevention Funding for States
 FY2001  $1,291,214

 FY2003   $1,342,688

 

Total Federal and State Funding for ADAP, FY2001  $1,153,308

Definitions: ADAPs: AIDS Drug Assistance Programs (ADAPs), authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV-related prescription drugs to underinsured and uninsured individuals living with HIV/AIDS. Each state or territory administers its own ADAP.

 

AIDS Drug Assistance Programs (ADAPs)
Source Kaiser Family Foundation

Total ADAP Clients Served, June 2002  
  NE
#		 US
#
   182 80,035

 
ADAP Clients Served by Sex, June 2002  
  NE
#		 NE
%		 US
#		 US
%
  Male 144 79 62,034 78
  Female 38 21 16,702 21
  Total 182 100 79,531 100

 
ADAP Clients Served by Race/Ethnicity, June 2002  
  NE
#		 NE
%		 US
#		 US
%
  White 111 61 29,426 37
  Black 36 20 26,245 33
  Hispanic 34 19 19,883 25
  Asian/Pacific Islander 0 0 795 1
  American Indian/Alaskan Native 1 1 795 1
  Other 0 0 795 1
  Total 182 100 79,531 100

 
ADAP Clients Served by Age, June 2002  
  NE
#		 NE
%		 US
#		 US
%
  <13 years old 0 0 795 1
  13-19 years old 6 3 0 1 0 1
  20-44 years old 130 71 50,105 63
  >44 years old 48 26 27,836 35
  Total 182 101 79,531 100

 
ADAP Clients Served by Income, June 2002  
  NE
#		 NE
%		 US
#		 US
%
  <100% FPL 0 0 38,175 48
  101-200% FPL 182 100 26,245 33
  201-300% FPL 0 0 8,748 11
  301-400% FPL 0 0 3,181 4
  >400% FPL 0 0 1,591 2
  Total 182 100 79,531 100

 
Insurance Coverage of ADAP Clients, June 2002  
  NE
#		 NE
%		 US
#		 US
%
  Medicaid 0 0 0 10
  Medicare 22 12 0 6
  Private 36 20 0 13

 
National ADAP Budget, Total Federal and State Sources, FY 2002  
  NE
$		 US
$
   1,338,370 878,610,754

 
National ADAP Budget by Source, FY 2002  
  NE
$		 NE
%		 US
$		 US
%
  ADAP Earmark 947,262 71 619,830,000 71
  Title II Base 54,312 4 28,886,192 3
  State 150,000 11 160,385,979 18
  Title I 0 0 19,736,619 2
  Other Federal 44,638 3 30,941,439 4
  ADAP Supplemental Grants 142,158 11 19,170,000 2
  Total 1,338,370 100 878,610,754 100

 
Total ADAP Drug Expenditures, June 2002  
  NE
$		 US
$
   108,241 70,705,142

 
ADAP Drug Expenditures by Drug Class, June 2002  
  NE
$		 NE
%		 US
$		 US
%
  Nucleoside Reverse Transcriptase Inhibitors 62,935 58 31,486,146 49
  non-Nucleoside Reverse Transcriptase Inhibitors 15,735 15 7,940,575 12
  Protease Inhibitors 20,604 19 16,433,502 25
  Opportunistic Infections/Other 8,967 8 9,015,329 14
  Total 108,241 100 64,875,793 100

 
Total ADAP Prescriptions Filled, June 2002  
  NE
#		 US
#
   387 257,279


 

ADAP Prescriptions Filled by Drug Class, June 2002  
  NE
#		 NE
%		 US
#		 US
%
  Nucleoside Reverse Transcriptase Inhibitors 179 46 83,166 36
  non-Nucleoside Reverse Transcriptase Inhibitors 60 16 23,933 10
  Protease Inhibitors 49 13 33,813 15
  Opportunistic Infections/Other 99 26 87,746 38
  Total 387 100 228,771 100

 
Federal ADAP Funds Used for Insurance Purchasing/Maintenance, FY 2002  
  NE
$		 US
$
   NA 18,486,544

 
ADAP Formularies, Number of Medications by Drug Class, 2002  
  NE
#		 US
#
  Nucleoside Reverse Transcriptase Inhibitors 9 NA
  Protease Inhibitors Covered 6 NA
  Non-nucleosides Covered 3 NA
  OI Prophylaxis Covered 0 NA
  Other Medications Covered 0 NA
  Total 18 NA

 
ADAP Emergency Cost Containment Measures, February 2003  
  NE
 		 US
 
  Has ADAP Emergency Cost Containment Measures in Place Yes 16 Yes
  Notes Capped enrollment; reduced formulary.